Combined Detection of IFN-γ and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times
-
Published:2023-04-27
Issue:6
Volume:80
Page:
-
ISSN:0343-8651
-
Container-title:Current Microbiology
-
language:en
-
Short-container-title:Curr Microbiol
Author:
Chen Yiwen,Zhang Lahong,Zhou Changjun,Liu Yuhua,Pan Feng,Ke Qiang,Chen Zhaojun
Abstract
AbstractThe immune status of mycobacterium tuberculosis (MTB) infection is essential for the diagnosis and treatment of this disease. In this work, we aim to evaluate the clinical significance of the combination of serum IFN-γ, IGRAs (Interferon-Gamma Release Assay), lymphocyte subset with activation indicators detection in active and latent tuberculosis infection patients. For this study, anticoagulant whole blood were collected from 45 active tuberculosis (AT group), 44 latent tuberculosis (LT group) and 32 healthy controls (HCs group). The serum IFN-γ and IGRAs detected by chemiluminescence, and the percentage of lymphocyte subsets and activated lymphocytes detected by flow cytometry. The results showed combined IGRAs, serum IFN-γ and NKT cells not only has good diagnostic efficiency for the AT, but also provides a laboratory diagnostic method to distinguish AT from LT. Activation indicator of CD3+HLA-DR+T and CD4+HLA-DR+T can effectively distinguish LT from HCs. While combined CD3+T, CD4+T, CD8+CD28+T, Treg and CD16+CD56+CD69+ cells can distinguish AT from HCs. This study showed combined direct detection of serum IFN-γ and IGRAs as well as lymphocyte subsets with activation indicators which may provide laboratory basis for the diagnosis and differential diagnosis of active and latent MTB infection.
Funder
Hangzhou Science and Technology Bureau
Medical Science and Technology Project of Zhejiang Province
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference27 articles.
1. World Health Organization (2020) Global tuberculosis report 2020. World Health Organization, Geneva
2. Shuo Y, Le W, Xiaotong Y et al (2021) Changes in peripheral blood lymphocyte subsets in children with active tuberculosiss. Chin J Microbiol Immunol 41(1):30–35
3. World Health Organization (2018) Latent tuberculosis infection: updated, consolidated guidelines for programmatic management. World Health Organization, Geneva
4. Marais BJ, Graham SM, Cotton MF et al (2007) Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis 196(s1):S76–S85
5. Blumberg HM, Ernst JD (2016) The challenge of latent TB infection. JAMA 316(9):931–933